Related references
Note: Only part of the references are listed.Insulin resistance, oxidative stress and mitochondrial defects in Ts65dn mice brain: A harmful synergistic path in down syndrome
Chiara Lanzillotta et al.
FREE RADICAL BIOLOGY AND MEDICINE (2021)
Brain insulin resistance triggers early onset Alzheimer disease in Down syndrome
Antonella Tramutola et al.
NEUROBIOLOGY OF DISEASE (2020)
BVR-A Deficiency Leads to Autophagy Impairment through the Dysregulation of AMPK/mTOR Axis in the Brain-Implications for Neurodegeneration
Chiara Lanzillotta et al.
ANTIOXIDANTS (2020)
Biliverdin Reductase-A Mediates the Beneficial Effects of Intranasal Insulin in Alzheimer Disease
Eugenio Barone et al.
MOLECULAR NEUROBIOLOGY (2019)
Dementia in Down syndrome: unique insights for Alzheimer disease research
Ira T. Lott et al.
NATURE REVIEWS NEUROLOGY (2019)
Association of Extracellular Vesicle Biomarkers With Alzheimer Disease in the Baltimore Longitudinal Study of Aging
Dimitrios Kapogiannis et al.
JAMA NEUROLOGY (2019)
mTOR in Down syndrome: Role in A beta and tau neuropathology and transition to Alzheimer disease-like dementia
Fabio Di Domenico et al.
FREE RADICAL BIOLOGY AND MEDICINE (2018)
Brain insulin resistance in type 2 diabetes and Alzheimer disease: concepts and conundrums
Steven E. Arnold et al.
NATURE REVIEWS NEUROLOGY (2018)
The Triangle of Death in Alzheimer's Disease Brain: The Aberrant Cross-Talk Among Energy Metabolism, Mammalian Target of Rapamycin Signaling, and Protein Homeostasis Revealed by Redox Proteomics
Fabio Di Domenico et al.
ANTIOXIDANTS & REDOX SIGNALING (2017)
Distinct Functions of Syntaxin-1 in Neuronal Maintenance, Synaptic Vesicle Docking, and Fusion in Mouse Neurons
Guelcin Vardar et al.
JOURNAL OF NEUROSCIENCE (2016)
Demonstrated brain insulin resistance in Alzheimer's disease patients is associated with IGF-1 resistance, IRS-1 dysregulation, and cognitive decline
Konrad Talbot et al.
JOURNAL OF CLINICAL INVESTIGATION (2012)